Motion Stimulation Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Functional Neuromuscular Motion Stimulation Therapy, Peripheral Motion Stimulation Therapy, Deep Brain Motion Stimulation Therapy, Others), By End User (Hospitals, Clinics, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Market Overview

The global motion stimulation therapy market size was valued at USD 1.30 billion in 2023. It is estimated to reach USD 1.87 billion by 2032, growing at a CAGR of 3.8% during the forecast period (2024–2032).

Motion stimulation therapy is a process that uses controlled movements which stimulate the muscles, the joints, and involved nerves. It is directed at bettering musculoskeletal functioning, improving mobility, and relieving pain, not using biomedical approaches. Devices in this treatment may include electric muscle stimulators, vibration therapy, or even robotic-aided movements.

The global market is witnessing significant growth driven by increasing awareness of non-pharmacological treatment options for pain management and rehabilitation. It uses controlled movement to enhance musculoskeletal function and hence plays an invaluable role in physiotherapy and sports medicine. With technological advancements, the accuracy and efficiency of motion stimulation devices has further increased, extending the usefulness of these devices among diverse patient groups. Growing health care expenditures and increased attention to comprehensive well-being support further the market motion stimulation therapy market. It is, however, the outcome of developed motion stimulation therapy outcomes in research and other findings that determine the existence of improved therapeutic regimens through which the marketing of future growth and creativity promises.

Market Dynamics

Global motion stimulation therapy market drivers:

Increasing demand for non-pharmacological pain management

There is a rising preference for non-pharmacological treatments due to concerns over opioid addiction and side effects associated with pain medications. Motion stimulation therapy offers a drug-free alternative that can effectively manage chronic pain conditions. For instance, devices like transcutaneous electrical nerve stimulation (TENS) units are used to provide pain relief by stimulating nerves with electrical impulses, reducing the reliance on painkillers.

Increasing incidence of musculoskeletal disorders

The rise of arthritis cases and chronic back pain, for instance, provides the most compelling reason for the promotion of motion stimulation therapy. In America, it is estimated by the centers of disease control and prevention that over 54 million Americans are adults suffering from arthritis, resulting in painful conditions and far from easy-mobility bodies. In recent times, stimulation therapies for motion have been increasingly favoured toward effective pain management that has minimal side effects related to the long-term use of medications. With the increasing incidence of musculoskeletal disease, the market for motion stimulation will be driven to expand in demand for non-invasive, drug-free therapies like transcutaneous electrical nerve stimulation.

Global motion stimulation therapy market restraint:

High cost of advanced devices

The cost of advanced motion stimulation therapy devices can be prohibitive for many patients and healthcare providers. Devices such as robotic-assisted rehabilitation equipment or high-end electric muscle stimulators often come with a high price tag due to the sophisticated technology and materials used. For instance, a state-of-the-art robotic exoskeleton for gait training can cost upwards of USD 100,000, limiting accessibility for smaller clinics or individual patients without sufficient insurance coverage. This financial barrier can impede widespread adoption, particularly in low- and middle-income regions.

Global motion stimulation therapy market opportunities:

Expanding applications in chronic disease management

Motion stimulation therapy can be utilized for the treatment of not just musculoskeletal diseases but also common chronic diseases, including diabetes and cardiovascular diseases. For instance, it has been observed from research that electric muscle stimulation is capable of improving circulation and enhancing muscle strengths among patients suffering from diabetes; hence, they reduce complications owing to diabetes, like diabetic neuropathy. Motion stimulation can also assist in the rehabilitation of heart disease patients through the enhancement of muscle activities and heart health. With an increase in incidents of chronic disease across the world, many possibilities arise in the development of motion stimulation therapy as part of chronic disease management protocols.

Regional Analysis

Based on region, the global motion stimulation therapy market share is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North america dominates the global market

North America is the most significant global motion stimulation therapy market shareholder and is expected to expand substantially during the forecast period. North America stands as a prominent region in the global motion stimulation therapy industry, characterized by advanced healthcare infrastructure, high healthcare expenditure, and technological advancements in diagnostic equipment. The region's leadership is underscored by robust investment in healthcare R&D, strong regulatory frameworks, and widespread adoption of advanced medical technologies.

The United States market for motion stimulation therapy is leading in terms of market share. The country has a large number of healthcare facilities, including hospitals, clinics, and surgical centers, all of which extensively use motion stimulation therapy for a motion related disease management.

The Canadian motion stimulation therapy industry is projected to grow because the Canadian market continues to leverage the benefits of well-developed public healthcare, which creates an organizational and financing framework supporting universal access to healthcare services. Growing awareness among healthcare professionals and patients about the benefits of non-pharmacological pain management and rehabilitation options further propels market growth.

These factors are estimated to drive the North American motion stimulation therapy market growth.

Asia-Pacific region is a pivotal market for the motion stimulation therapy industry, witnessing robust growth driven by rapid industrialization, urbanization, and economic development. The region's expanding healthcare industry, supportive government policies, and increasing adoption of innovative medical technologies.

China's motion stimulation therapy market has a major role in shaping the dynamics of the Asia-Pacific motion stimulation therapy market. The large population in China and increased incidence of chronic pain and musculoskeletal disorders, necessitating effective rehabilitation and pain management solutions, drive substantial demand in the market.

India's market is witnessing rapid growth driven by the country's large and diverse population, coupled with increasing healthcare awareness and government initiatives to enhance healthcare accessibility, are key factors contributing to market expansion.

Thus, the factors above are estimated to boost the Asia-Pacific motion stimulation therapy market growth.

Segmental Analysis

The global motion stimulation therapy market is segmented by therapy type and end user.

Based on therapy type, the global motion stimulation therapy market is divided into functional neuromuscular motion stimulation therapy, peripheral motion stimulation therapy, deep brain motion stimulation therapy and others. 

Based on therapy type, functional neuromuscular motion stimulation therapy dominates the global motion stimulation therapy industry. The reason for the dominance of this segment is its widespread application for the treatment of varied neuromuscular conditions, such as stroke rehabilitation, spinal cord injuries, and muscular dystrophy. Functional neuromuscular motion stimulation therapy is generally indicated for increased recovery of muscle function and movement, achieved by facilitating motor recovery of patients with neurological disorders. The clinical validity and increasing popularity of functional neuromuscular motion stimulation therapy for restoring movement and function have become efficacious in treatment for patients suffering from severe motor impairments. Healthcare professionals, therefore, consider functional neuromuscular motion stimulation therapy as the best approach for the treatment of complex neuromuscular challenges and for better patient outcomes, thus making this therapy dominant in the market for motion stimulation.

Based on application, the global market for motion stimulation therapy is bifurcated into basic diabetes management, pain management, oncology, cardiovascular diseases, infectious diseases and others. 

Based on end users, the hospitals segment dominates the global motion stimulation therapy market. Hospitals have sufficient resources, high-level medical technologies, and professional rehabilitation departments that offer diversified services for different therapeutic needs. Rehabilitative treatments and pain management are delivered within this kind of setting, so motion stimulation therapies featuring transcutaneous electrical nerve stimulation (TENS) and electric muscle stimulations (EMS) are very vital. Moreover, hospitals are the complete care settings wherein a patient can be provided with a completely integrated treatment plan that uses motion stimulation therapy in combination with other medical remedies as well. This takes care right from acute treatment to rehabilitation, high levels of utilization rates in motion stimulation therapies make the hospitals segment the market's leading end user.

Recent Developments

• In April 2024, leading global provider of medical technology, Medtronic plc, stated that the FDA in the United States approved Inceptiv, a rechargeable spinal cord stimulator (SCS) intended for the treatment of chronic pain.

Analyst’s Perspective:

As per our research analysts, the motion stimulation therapy market has a very promising landscape, with the potential for high growth impelled by increasing demand for non-pharmacological pain management solutions, rapid developments in medical technology, and a rise in the global burden of chronic pain and musculoskeletal disorders. Growing awareness among patients and healthcare providers about the safety and efficacy of transcutaneous electrical nerve stimulation and electric muscle stimulation benefits the market. Additionally, demographic trends, including an aging population and the growing burden of lifestyle-related diseases, further fuel market expansion.